These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 6870634)

  • 1. Outward transport of fluorescein from the vitreous in normal human subjects.
    Blair NP; Zeimer RC; Rusin MM; Cunha-Vaz JG
    Arch Ophthalmol; 1983 Jul; 101(7):1117-21. PubMed ID: 6870634
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estimation of the permeability of the blood-retinal barrier in normal individuals.
    Oguro Y; Tsukahara Y; Saito I; Kondo T
    Invest Ophthalmol Vis Sci; 1985 Jul; 26(7):969-76. PubMed ID: 4008211
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fluorescein transport across the human blood-retina barrier in the direction vitreous to blood. Quantitative assessment in vivo.
    Engler CB; Sander B; Larsen M; Dalgaard P; Lund-Andersen H
    Acta Ophthalmol (Copenh); 1994 Dec; 72(6):655-62. PubMed ID: 7747570
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transport of fluorescein in the ocular posterior segment in retinitis pigmentosa.
    Mallick KS; Zeimer RC; Fishman GA; Blair NP; Anderson RJ
    Arch Ophthalmol; 1984 May; 102(5):691-6. PubMed ID: 6721754
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outward transport of fluorescein from the vitreous in normal human subjects.
    Blair NP; Zeimer RC; Rusin M; Cunha-Vaz JG
    Graefes Arch Clin Exp Ophthalmol; 1985; 222(4-5):266. PubMed ID: 3979854
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Probenecid inhibition of the outward transport of fluorescein across the human blood-retina barrier.
    Engler CB; Sander B; Larsen M; Koefoed P; Parving HH; Lund-Andersen H
    Acta Ophthalmol (Copenh); 1994 Dec; 72(6):663-7. PubMed ID: 7747571
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blood-retinal barrier permeability to carboxyfluorescein and fluorescein in monkeys.
    Blair NP; Rusin MM
    Graefes Arch Clin Exp Ophthalmol; 1986; 224(5):419-22. PubMed ID: 3093315
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of acetazolamide on outward permeability of blood-retina barrier using differential vitreous flyorophotometry.
    Takahashi J; Mori F; Hikichi T; Yoshida A
    Curr Eye Res; 2001 Sep; 23(3):166-70. PubMed ID: 11803477
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Binding of fluorescein to vitreous in vitro.
    Knudsen LL
    Acta Ophthalmol (Copenh); 1987 Jun; 65(3):352-7. PubMed ID: 3618161
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative vitreous fluorophotometry applying a mathematical model of the eye.
    Lund-Andersen H; Krogsaa B; la Cour M; Larsen J
    Invest Ophthalmol Vis Sci; 1985 May; 26(5):698-710. PubMed ID: 3997419
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetic interpretation of vitreous fluorophotometry.
    Zeimer RC; Blair NP; Cunha-Vaz JG
    Invest Ophthalmol Vis Sci; 1983 Oct; 24(10):1374-81. PubMed ID: 6618797
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Measurement of blood-retinal barrier permeability: a reproducibility study in normal eyes.
    Chahal PS; Chowienczyk PJ; Kohner EM
    Invest Ophthalmol Vis Sci; 1985 Jul; 26(7):977-82. PubMed ID: 4008212
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of fluorescein in the vitreous.
    Palestine AG; Brubaker RF
    Invest Ophthalmol Vis Sci; 1981 Oct; 21(4):542-9. PubMed ID: 7287343
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Posterior vitreous fluorophotometry. I. Description of a new analysis procedure and results in normal subjects.
    Bungay PM; Roy MS; Bonner RF
    Arch Ophthalmol; 1989 Sep; 107(9):1321-7. PubMed ID: 2783065
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fluid dynamics in eyes with rhegmatogenous retinal detachments.
    Tsuboi S; Taki-Noie J; Emi K; Manabe R
    Am J Ophthalmol; 1985 Jun; 99(6):673-6. PubMed ID: 4014391
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inward and outward permeability of the blood-retinal barrier in experimental myopia.
    Yoshida A; Ishiko S; Kojima M
    Graefes Arch Clin Exp Ophthalmol; 1996 Aug; 234 Suppl 1():S239-42. PubMed ID: 8871181
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Calculation of the permeability of the blood-retinal barrier to fluorescein.
    Lund-Andersen H; Krogsaa B; Larsen J
    Graefes Arch Clin Exp Ophthalmol; 1985; 222(4-5):173-6. PubMed ID: 3979839
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fluorescein and fluorescein glucuronide in the vitreous body of diabetic patients.
    Lund-Andersen H; Larsen M; Dalgaard P; Olsen W
    Graefes Arch Clin Exp Ophthalmol; 1987; 225(3):173-6. PubMed ID: 3609757
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vitreous fluorophotometry in patients with no or minimal diabetic retinopathy.
    Chahal P; Fallon TJ; Jennings SJ; Chowienczyk PJ; Kohner EM
    Diabetes Care; 1986; 9(2):134-9. PubMed ID: 3698779
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Technical variables in vitreous fluorophotometry.
    Conway BP
    Graefes Arch Clin Exp Ophthalmol; 1985; 222(4-5):194-201. PubMed ID: 3979842
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.